Accurate protein expression quantification is critical to advance and accelerate gene therapy development. However, measuring protein expression reproducibly is a challenge for many traditional assays due to limitations in sensitivity and selectivity. For today’s gene therapy developer, Ion Mobility Spectrometry...
The pharmaceutical industry, especially emerging biopharma, is experiencing rapid and transformative growth. Over the past five years, the U.S. biotechnology industry has seen a compound annual growth rate (CAGR) of 7.2%, reaching $215.4 billion in revenue with an anticipated growth...
Struggling with low abundance or isobaric species in complex samples? Discover how to overcome barriers in sensitivity and selectivity with our in-depth whitepaper on Addressing Challenges in Protein Quantitation with Ion Mobility Spectrometry (IMS)—a cutting-edge solution reshaping modern biopharmaceutical drug...
In this AAPS eChalk Talk, our speakers will explore how Ion Mobility Spectrometry (IMS) is revolutionizing mass spectrometry by enhancing sensitivity and selectivity. They will discuss the advances in mass spectrometry and increase in throughput speed, specifically as it pertains...
Biomarker Discovery & Validation Developing and validating assays that can be used to measure biomarkers in biological samples is crucial in biomarker discovery. Biomarkers are biological indicators of a particular disease or condition. They can be used to diagnose, monitor,...
A sponsor focused on the development of a groundbreaking iron nanoparticle – a colloidal iron oxide particle stabilized by sucrose for gastrointestinal cancers sought collaboration with Sannova Analytical for a unique approach and solution. Check out the video to know...
This whitepaper offers a critical roadmap for navigating the complexities of regulatory compliance in biologic therapy development. Highlighting innovative strategies for chemical manufacturing and controls (CMC), this guide emphasizes laboratory practices and analytical methods to mitigate impurities, contamination, and toxicity,...
Oligonucleotide therapies, including small interfering RNA (siRNA), microRNA (miRNA), and inhibitory antisense oligonucleotides (ASOs), have emerged as a promising group of molecules for gene inhibition (Hu et al., 2020). These therapies hold particular potential in addressing rare diseases that lack...